Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and no
Molecular Weight:
Approximately 146.48 kDa.
CAS Number:
[1660159-36-3]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted